Insights Gleaned from Asthma Research for COPD

Author(s):

Fernando J. Martinez, MD, MS,Nicola Hanania, MD, MS

1) Nicola A. Hanania, MD, MS, discusses what we have learned from asthma research on the involvement of type 2 inflammation that is applicable to COPD.

EP: 2.COPD Traits Associated with Phenotypes

Now Viewing

EP: 3.Insights Gleaned from Asthma Research for COPD

EP: 5.Unmet Needs in the COPD Treatment Landscape

EP: 6.The Role of Eosinophils in Diagnosing COPD

EP: 7.GOLD Treatment Guidelines and Evolving Therapeutic Approaches

EP: 8.Evolving Treatment Landscape in COPD

EP: 9.Emerging Treatment Approaches in COPD

EP: 10.Future Treatment Landscape for COPD

EP: 11.The Benefits of Earlier Diagnosis and Treatment of COPD

EP: 12.The Relationship Between Comorbidities in COPD

EP: 13.The Role of Primary Care Providers in Managing Patients with COPD

EP: 14.Key Takeaways on the Evolving COPD Treatment Landscape

What have we learned from asthma research on the involvement of type 2 inflammation that is applicable to COPD? Can you discuss the pathophysiology of COPD cytokines and immune cells commonly elevated in patients with type 2 inflammation.